15-12B 1 brhc10032860_1512b.htm 15-12B

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-06639

MAGELLAN HEALTH, INC.

(Exact name of registrant as specified in its charter)

4801 Washington Street

Phoenix, Arizona 85034

(800) 642-1716

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.01 par value per share

(Title of each class of securities covered by this Form)

None

(Title of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)

☒

	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(i)	☒
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Magellan Health, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: January 14, 2022	MAGELLAN HEALTH, INC.

	By:	/s/ Christopher Koster
	Name:	Christopher Koster
	Title:	Secretary

SEC Form 15-12B filed by Magellan Health, Inc.